ImmunoGen, Inc. Profile Avatar - Palmy Investing

ImmunoGen, Inc.

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase…
Biotechnology
US, Waltham [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

A quick analysis that compared ImmunoGen, Inc. (IMGN) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.

Company Price Change Volume, Avg. Market Cap. Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding
Biotechnology Average - - - - - - 14,121.17 927.10 141.67 283.82 17.26 0.00 23.6415 -0.83 -0.9506 -22.0227 -0.09 -0.10 7.1468 - -
Maximum - - - - - - 444,129.00 65,349.00 25,407.00 99,050.00 5,305.00 0.02 1,336.3467 6.70 3.0051 85.3485 0.15 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -6,783.00 -56,335.00 -2,077.00 0.00 -164.8536 -57.22 -101.7758 -1,444.7800 -1.56 -12.64 0.0007 - -
Axsome Therapeutics, Inc. AXSM 98.19 3.59 3.79% 787 vs. 460 4,758.00 74.00 -68.00 - - - - -1.4400 - - - - 0.8916 - - - - - - - - 48.00
Reata Pharmaceuticals, Inc. RETA 172.36 0.04 0.02% 1,909 vs. 954 6,566.00 22.00 192.00 -70.00 -1,490.00 5.1200 5.4820 0.0000 0.9628 8.4849 2.2110 0.3840 2.8209 38.00
TG Therapeutics, Inc. TGTX 34.55 3.40 10.91% 5,616 vs. 3,704 5,378.00 63.00 -10.00 -8.00 -1,525.00 -0.0732 -50.4229 0.0000 0.9130 -0.1687 -0.0669 -0.0287 2.7564 155.00
Madrigal Pharmaceuticals, Inc. MDGL 329.24 12.15 3.83% 421 vs. 376 7,180.00 0.00 -147.00 -149.00 -1,483.00 -7.3800 -8.6674 0.0000 0.0000 0.0000 -0.1734 -0.1363 9.2623 21.00
ImmunoGen, Inc. IMGN 31.23 0.01 0.02% 19,311 vs. 8,287 8,725.00 113.00 30.00 1.00 -1,708.00 0.1000 37.1085 0.0000 0.9810 0.2711 0.0548 0.0374 5.4673 279.00
Akero Therapeutics, Inc. AKRO 31.20 0.57 1.84% 522 vs. 551 2,177.00 0.00 -53.00 -35.00 -627.00 -0.9000 -6.6902 0.0000 0.0000 0.0000 -0.0630 -0.0585 29.8643 69.00
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for IMGN and its peers to uncover potential buy and sell opportunities.
End of IMGN's Analysis
CIK: 855654 CUSIP: 45253H101 ISIN: US45253H1014 LEI: - UEI: -
Secondary Listings